- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02041598
DREAM Project Community Health Worker Intervention
October 16, 2017 updated by: NYU Langone Health
The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC).
For a two-arm, randomized controlled trial (RCT), investigators will recruit a sample of 256 participants, all of whom are 1) of Bangladeshi descent, 2) residing in NYC, 3) diagnosed with Type 2 diabetes mellitus (T2DM) and a recent Hemoglobin A1c (HbA1c) of ≥ 6.5, and 4) between the ages of 21-85.
The treatment group receives a six-month CHW-led intervention consisting of five monthly group educational sessions, two one-on-one visits, and follow-up phone calls as needed from a CHW.
The control group receives an introductory educational session only.
Primary and secondary outcomes include clinical and behavioral measures, such as HbA1c and weight change, access to and utilization of care (i.e.
appointment keeping and use of specialty care), and knowledge and practice of physical activity and healthful eating.
Additionally, information regarding CHW characteristics, the processes and mechanisms for influencing healthful behavior change, and fidelity of the intervention are collected.
Outcomes are measured at Baseline, 3-Months, 6-Months for both groups, and at 12-Months for the treatment group.
Study Type
Interventional
Enrollment (Actual)
441
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine, Dept of Population Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- confirmed clinical diagnosis of T2DM with a Hemoglobin A1c (HbA1c) of ≥ 6.5%; and
- male or female between the ages of 21-85 years old; and
- willingness to be randomized to either treatment or control groups.
Exclusion Criteria:
- is or was on renal dialysis;
- experiencing an acute or terminal illness or serious mental illness;
- had a history of recent coronary event within the last 3 months of recruitment;
- is pregnant at the time of recruitment;
- experienced other severe medical conditions that might preclude participation;
- has poor short-term prognosis (expected death in <2 years); or
- is participating in another research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Full CHW Intervention
5 monthly group educational sessions, 2 1v1 Visits with CHW, Phone Calls as Needed
|
5 group educational sessions, 2 1v1 Visits with a CHW, Phone Calls as needed during 6-month study period
|
No Intervention: Control: Intro to Diabetes Session Only
One-time, Introduction to Diabetes educational session only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Baseline Hemoglobin A1c at 6-Months
Time Frame: Baseline, 6-Months
|
Change in Baseline HbA1c at 6-Months
|
Baseline, 6-Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Baseline Perceived Social Support at 6-Months
Time Frame: Baseline, 6-Months
|
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
|
Baseline, 6-Months
|
Change in Baseline Perceived Benefits & Barriers at 6-Months
Time Frame: Baseline, 6-Months
|
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
|
Baseline, 6-Months
|
Change in Baseline Self-Efficacy at 6-Months
Time Frame: Baseline, 6-Months
|
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
|
Baseline, 6-Months
|
Change in Baseline Access to / Utilization of healthcare at 6-Months
Time Frame: Baseline, 6-Months
|
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
|
Baseline, 6-Months
|
Change in Baseline Diabetic Management Practices & Knowledge at 6-Months
Time Frame: Baseline, 6-Months
|
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
|
Baseline, 6-Months
|
Change in Baseline Engagement in Physical Activity & Healthy eating at 6-Months
Time Frame: Baseline, 6-Months
|
Assessed using scale items on questionnaire instrument administered during semi-structured interview at each timepoint
|
Baseline, 6-Months
|
Change in Baseline Lipid Profile at 6-Months
Time Frame: Baseline, 6-Months
|
HDL, LDL, Triglycerides, Total Cholesterol
|
Baseline, 6-Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nadia Islam, PhD, New York University School of Medicine, Department of Population Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Islam NS, Wyatt LC, Patel SD, Shapiro E, Tandon SD, Mukherji BR, Tanner M, Rey MJ, Trinh-Shevrin C. Evaluation of a community health worker pilot intervention to improve diabetes management in Bangladeshi immigrants with type 2 diabetes in New York City. Diabetes Educ. 2013 Jul-Aug;39(4):478-93. doi: 10.1177/0145721713491438. Epub 2013 Jun 7.
- Wyatt LC, Katigbak C, Riley L, Zanowiak JM, Ursua R, Kwon SC, Trinh-Shevrin C, Islam NS. Promoting Physical Activity Among Immigrant Asian Americans: Results from Four Community Health Worker Studies. J Immigr Minor Health. 2022 Oct 23. doi: 10.1007/s10903-022-01411-y. Online ahead of print.
- Islam N, Riley L, Wyatt L, Tandon SD, Tanner M, Mukherji-Ratnam R, Rey M, Trinh-Shevrin C. Protocol for the DREAM Project (Diabetes Research, Education, and Action for Minorities): a randomized trial of a community health worker intervention to improve diabetic management and control among Bangladeshi adults in NYC. BMC Public Health. 2014 Feb 18;14:177. doi: 10.1186/1471-2458-14-177.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2009
Primary Completion (Actual)
February 25, 2016
Study Completion (Actual)
February 25, 2016
Study Registration Dates
First Submitted
January 16, 2014
First Submitted That Met QC Criteria
January 21, 2014
First Posted (Estimate)
January 22, 2014
Study Record Updates
Last Update Posted (Actual)
October 18, 2017
Last Update Submitted That Met QC Criteria
October 16, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-0510
- P60MD000538 (U.S. NIH Grant/Contract)
- U48DP001904 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
-
Newsoara Biopharma Co., Ltd.RecruitingT2DM (Type 2 Diabetes Mellitus)China
Clinical Trials on CHW Intervention
-
NYU Langone HealthCompletedHypertension | Hypertensive Heart DiseaseUnited States
-
Public Health - Seattle and King CountyCenters for Disease Control and PreventionCompleted
-
University of FloridaCompleted
-
Public Health - Seattle and King CountyPatient-Centered Outcomes Research InstituteUnknown
-
University of MinnesotaNot yet recruiting
-
Johns Hopkins Bloomberg School of Public HealthMakerere UniversityCompletedHealth Behavior | Health Care Utilization | IncentivesUganda
-
University of Texas Southwestern Medical CenterNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
St. John's Research InstituteNational Heart and Lung InstituteCompletedAcute Coronary SyndromeIndia
-
The University of Texas Health Science Center,...Cancer Prevention Research Institute of TexasCompletedCervical Cancer | Breast CancerUnited States